AKT1 and ovarian carcinoma: Hypermethylation-mediated repression of cell adhesion and tight junction pathways, and hypomethylation-mediated activation of the cell growth-promoting pathways PI3K/Akt and TGF-beta, and cell cycle progression may contribute to the onset of chemo-resistance in ovarian cancer cells [15].